Loading…
An arched micro-injector (ARCMI) for innocuous subretinal injection
Several critical ocular diseases that can lead to blindness are due to retinal disorders. Subretinal drug delivery has been developed recently for the treatment of retinal disorders such as hemorrhage because of the specific ocular structure, namely, the blood retinal barrier (BRB). In the present s...
Saved in:
Published in: | PloS one 2014-08, Vol.9 (8), p.e104145 |
---|---|
Main Authors: | , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c526t-7c6c0693453f53bf51ba834638f30f67e9b7a575581ff5095282fef1679aa4f73 |
---|---|
cites | cdi_FETCH-LOGICAL-c526t-7c6c0693453f53bf51ba834638f30f67e9b7a575581ff5095282fef1679aa4f73 |
container_end_page | |
container_issue | 8 |
container_start_page | e104145 |
container_title | PloS one |
container_volume | 9 |
creator | You, Yong Sung Lee, Chang Yeol Li, Chengguo Lee, Sung Ho Kim, Kibom Jung, Hyungil |
description | Several critical ocular diseases that can lead to blindness are due to retinal disorders. Subretinal drug delivery has been developed recently for the treatment of retinal disorders such as hemorrhage because of the specific ocular structure, namely, the blood retinal barrier (BRB). In the present study, we developed an Arched Micro-injector (ARCMI) for subretinal drug delivery with minimal retinal tissue damage. ARCMIs were fabricated using three major techniques: reverse drawing lithography, controlled air flow, and electroplating. In order to achieve minimal retinal tissue damage, ARCMIs were fabricated with specific features such as a 0.15 mm(-1) curvature, 45° tip bevel, 5 mm length, inner diameter of 40 µm, and an outer diameter of 100 µm. These specific features were optimized via in-vitro experiments in artificial ocular hemispherical structures and subretinal injection of indocyanine green in porcine eye ex-vivo. We confirmed that the ARCMI was capable of delivering ocular drugs by subretinal injection without unusual subretinal tissue damage, including hemorrhage. |
doi_str_mv | 10.1371/journal.pone.0104145 |
format | article |
fullrecord | <record><control><sourceid>proquest_plos_</sourceid><recordid>TN_cdi_plos_journals_1552644564</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_f8d64e62b10241dbaecfe9a07576a541</doaj_id><sourcerecordid>3399487631</sourcerecordid><originalsourceid>FETCH-LOGICAL-c526t-7c6c0693453f53bf51ba834638f30f67e9b7a575581ff5095282fef1679aa4f73</originalsourceid><addsrcrecordid>eNp1kUtr3DAUhUVoaNKk_yAkhm7ahSe6etqbwjD0MZBQKO1ayLKUaPBIU8ku9N9Xk3FCsshKF91zv3Olg9AF4AVQCdebOKWgh8UuBrvAgBkwfoROoaWkFgTTN8_qE_Qu5w3GnDZCvEUnhAMAF-QUrZah0snc277aepNi7cPGmjGm6uPy5-p2_alypfYhRDPFKVd56pIdfTGuDkofwzk6dnrI9v18nqHfX7_8Wn2vb358W6-WN7XhRIy1NMJg0VLGqeO0cxw63VAmaOModkLatpOaS84bcI7jlpOGOOtAyFZr5iQ9Q1cH7m6IWc3vzwp4wTPGBSuK9UHRR71Ru-S3Ov1TUXv1cBHTndJp9GawyjW9YFaQDjBh0HfaGmdbjSWXQnMGhfV5dpu6re2NDWPSwwvoy07w9-ou_lUMSFMoBfBhBqT4Z7J5fGVldlCVz885WffkAFjtg36cUvug1Rx0Gbt8vt3T0GOy9D9DcqWM</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1552644564</pqid></control><display><type>article</type><title>An arched micro-injector (ARCMI) for innocuous subretinal injection</title><source>Publicly Available Content Database (Proquest) (PQ_SDU_P3)</source><source>PubMed Central</source><creator>You, Yong Sung ; Lee, Chang Yeol ; Li, Chengguo ; Lee, Sung Ho ; Kim, Kibom ; Jung, Hyungil</creator><contributor>Prow, Tarl Wayne</contributor><creatorcontrib>You, Yong Sung ; Lee, Chang Yeol ; Li, Chengguo ; Lee, Sung Ho ; Kim, Kibom ; Jung, Hyungil ; Prow, Tarl Wayne</creatorcontrib><description>Several critical ocular diseases that can lead to blindness are due to retinal disorders. Subretinal drug delivery has been developed recently for the treatment of retinal disorders such as hemorrhage because of the specific ocular structure, namely, the blood retinal barrier (BRB). In the present study, we developed an Arched Micro-injector (ARCMI) for subretinal drug delivery with minimal retinal tissue damage. ARCMIs were fabricated using three major techniques: reverse drawing lithography, controlled air flow, and electroplating. In order to achieve minimal retinal tissue damage, ARCMIs were fabricated with specific features such as a 0.15 mm(-1) curvature, 45° tip bevel, 5 mm length, inner diameter of 40 µm, and an outer diameter of 100 µm. These specific features were optimized via in-vitro experiments in artificial ocular hemispherical structures and subretinal injection of indocyanine green in porcine eye ex-vivo. We confirmed that the ARCMI was capable of delivering ocular drugs by subretinal injection without unusual subretinal tissue damage, including hemorrhage.</description><identifier>ISSN: 1932-6203</identifier><identifier>EISSN: 1932-6203</identifier><identifier>DOI: 10.1371/journal.pone.0104145</identifier><identifier>PMID: 25111562</identifier><language>eng</language><publisher>United States: Public Library of Science</publisher><subject>Air flow ; Airflow ; Animals ; Biology and Life Sciences ; Biomimetics ; Biotechnology ; Blindness ; Choroid - cytology ; Curvature ; Damage ; Disorders ; Drug delivery ; Drug delivery systems ; Electroplating ; Equipment Design ; Hemorrhage ; Humans ; Injection ; Injectors ; Macular degeneration ; Mechanical Phenomena ; Medicine and Health Sciences ; Microinjections - adverse effects ; Microinjections - instrumentation ; Retina ; Retina - cytology ; Swine</subject><ispartof>PloS one, 2014-08, Vol.9 (8), p.e104145</ispartof><rights>2014 You et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2014 You et al 2014 You et al</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c526t-7c6c0693453f53bf51ba834638f30f67e9b7a575581ff5095282fef1679aa4f73</citedby><cites>FETCH-LOGICAL-c526t-7c6c0693453f53bf51ba834638f30f67e9b7a575581ff5095282fef1679aa4f73</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/1552644564/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/1552644564?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25753,27924,27925,37012,44590,53791,53793,75126</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25111562$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>Prow, Tarl Wayne</contributor><creatorcontrib>You, Yong Sung</creatorcontrib><creatorcontrib>Lee, Chang Yeol</creatorcontrib><creatorcontrib>Li, Chengguo</creatorcontrib><creatorcontrib>Lee, Sung Ho</creatorcontrib><creatorcontrib>Kim, Kibom</creatorcontrib><creatorcontrib>Jung, Hyungil</creatorcontrib><title>An arched micro-injector (ARCMI) for innocuous subretinal injection</title><title>PloS one</title><addtitle>PLoS One</addtitle><description>Several critical ocular diseases that can lead to blindness are due to retinal disorders. Subretinal drug delivery has been developed recently for the treatment of retinal disorders such as hemorrhage because of the specific ocular structure, namely, the blood retinal barrier (BRB). In the present study, we developed an Arched Micro-injector (ARCMI) for subretinal drug delivery with minimal retinal tissue damage. ARCMIs were fabricated using three major techniques: reverse drawing lithography, controlled air flow, and electroplating. In order to achieve minimal retinal tissue damage, ARCMIs were fabricated with specific features such as a 0.15 mm(-1) curvature, 45° tip bevel, 5 mm length, inner diameter of 40 µm, and an outer diameter of 100 µm. These specific features were optimized via in-vitro experiments in artificial ocular hemispherical structures and subretinal injection of indocyanine green in porcine eye ex-vivo. We confirmed that the ARCMI was capable of delivering ocular drugs by subretinal injection without unusual subretinal tissue damage, including hemorrhage.</description><subject>Air flow</subject><subject>Airflow</subject><subject>Animals</subject><subject>Biology and Life Sciences</subject><subject>Biomimetics</subject><subject>Biotechnology</subject><subject>Blindness</subject><subject>Choroid - cytology</subject><subject>Curvature</subject><subject>Damage</subject><subject>Disorders</subject><subject>Drug delivery</subject><subject>Drug delivery systems</subject><subject>Electroplating</subject><subject>Equipment Design</subject><subject>Hemorrhage</subject><subject>Humans</subject><subject>Injection</subject><subject>Injectors</subject><subject>Macular degeneration</subject><subject>Mechanical Phenomena</subject><subject>Medicine and Health Sciences</subject><subject>Microinjections - adverse effects</subject><subject>Microinjections - instrumentation</subject><subject>Retina</subject><subject>Retina - cytology</subject><subject>Swine</subject><issn>1932-6203</issn><issn>1932-6203</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNp1kUtr3DAUhUVoaNKk_yAkhm7ahSe6etqbwjD0MZBQKO1ayLKUaPBIU8ku9N9Xk3FCsshKF91zv3Olg9AF4AVQCdebOKWgh8UuBrvAgBkwfoROoaWkFgTTN8_qE_Qu5w3GnDZCvEUnhAMAF-QUrZah0snc277aepNi7cPGmjGm6uPy5-p2_alypfYhRDPFKVd56pIdfTGuDkofwzk6dnrI9v18nqHfX7_8Wn2vb358W6-WN7XhRIy1NMJg0VLGqeO0cxw63VAmaOModkLatpOaS84bcI7jlpOGOOtAyFZr5iQ9Q1cH7m6IWc3vzwp4wTPGBSuK9UHRR71Ru-S3Ov1TUXv1cBHTndJp9GawyjW9YFaQDjBh0HfaGmdbjSWXQnMGhfV5dpu6re2NDWPSwwvoy07w9-ou_lUMSFMoBfBhBqT4Z7J5fGVldlCVz885WffkAFjtg36cUvug1Rx0Gbt8vt3T0GOy9D9DcqWM</recordid><startdate>20140811</startdate><enddate>20140811</enddate><creator>You, Yong Sung</creator><creator>Lee, Chang Yeol</creator><creator>Li, Chengguo</creator><creator>Lee, Sung Ho</creator><creator>Kim, Kibom</creator><creator>Jung, Hyungil</creator><general>Public Library of Science</general><general>Public Library of Science (PLoS)</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QG</scope><scope>7QL</scope><scope>7QO</scope><scope>7RV</scope><scope>7SN</scope><scope>7SS</scope><scope>7T5</scope><scope>7TG</scope><scope>7TM</scope><scope>7U9</scope><scope>7X2</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABJCF</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>ATCPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>D1I</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB.</scope><scope>KB0</scope><scope>KL.</scope><scope>L6V</scope><scope>LK8</scope><scope>M0K</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>M7S</scope><scope>NAPCQ</scope><scope>P5Z</scope><scope>P62</scope><scope>P64</scope><scope>PATMY</scope><scope>PDBOC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PTHSS</scope><scope>PYCSY</scope><scope>RC3</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20140811</creationdate><title>An arched micro-injector (ARCMI) for innocuous subretinal injection</title><author>You, Yong Sung ; Lee, Chang Yeol ; Li, Chengguo ; Lee, Sung Ho ; Kim, Kibom ; Jung, Hyungil</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c526t-7c6c0693453f53bf51ba834638f30f67e9b7a575581ff5095282fef1679aa4f73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Air flow</topic><topic>Airflow</topic><topic>Animals</topic><topic>Biology and Life Sciences</topic><topic>Biomimetics</topic><topic>Biotechnology</topic><topic>Blindness</topic><topic>Choroid - cytology</topic><topic>Curvature</topic><topic>Damage</topic><topic>Disorders</topic><topic>Drug delivery</topic><topic>Drug delivery systems</topic><topic>Electroplating</topic><topic>Equipment Design</topic><topic>Hemorrhage</topic><topic>Humans</topic><topic>Injection</topic><topic>Injectors</topic><topic>Macular degeneration</topic><topic>Mechanical Phenomena</topic><topic>Medicine and Health Sciences</topic><topic>Microinjections - adverse effects</topic><topic>Microinjections - instrumentation</topic><topic>Retina</topic><topic>Retina - cytology</topic><topic>Swine</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>You, Yong Sung</creatorcontrib><creatorcontrib>Lee, Chang Yeol</creatorcontrib><creatorcontrib>Li, Chengguo</creatorcontrib><creatorcontrib>Lee, Sung Ho</creatorcontrib><creatorcontrib>Kim, Kibom</creatorcontrib><creatorcontrib>Jung, Hyungil</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Animal Behavior Abstracts</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Nursing & Allied Health Database</collection><collection>Ecology Abstracts</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Meteorological & Geoastrophysical Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Agricultural Science Collection</collection><collection>ProQuest - Health & Medical Complete保健、医学与药学数据库</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Materials Science & Engineering Collection</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>Advanced Technologies & Aerospace Database (1962 - current)</collection><collection>Agricultural & Environmental Science Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Materials Science Collection</collection><collection>ProQuest Central</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Materials Science Database</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Meteorological & Geoastrophysical Abstracts - Academic</collection><collection>ProQuest Engineering Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>Agriculture Science Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>ProQuest Biological Science Journals</collection><collection>Engineering Database</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest advanced technologies & aerospace journals</collection><collection>ProQuest Advanced Technologies & Aerospace Collection</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Environmental Science Database</collection><collection>Materials science collection</collection><collection>Publicly Available Content Database (Proquest) (PQ_SDU_P3)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Engineering collection</collection><collection>Environmental Science Collection</collection><collection>Genetics Abstracts</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>PloS one</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>You, Yong Sung</au><au>Lee, Chang Yeol</au><au>Li, Chengguo</au><au>Lee, Sung Ho</au><au>Kim, Kibom</au><au>Jung, Hyungil</au><au>Prow, Tarl Wayne</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>An arched micro-injector (ARCMI) for innocuous subretinal injection</atitle><jtitle>PloS one</jtitle><addtitle>PLoS One</addtitle><date>2014-08-11</date><risdate>2014</risdate><volume>9</volume><issue>8</issue><spage>e104145</spage><pages>e104145-</pages><issn>1932-6203</issn><eissn>1932-6203</eissn><abstract>Several critical ocular diseases that can lead to blindness are due to retinal disorders. Subretinal drug delivery has been developed recently for the treatment of retinal disorders such as hemorrhage because of the specific ocular structure, namely, the blood retinal barrier (BRB). In the present study, we developed an Arched Micro-injector (ARCMI) for subretinal drug delivery with minimal retinal tissue damage. ARCMIs were fabricated using three major techniques: reverse drawing lithography, controlled air flow, and electroplating. In order to achieve minimal retinal tissue damage, ARCMIs were fabricated with specific features such as a 0.15 mm(-1) curvature, 45° tip bevel, 5 mm length, inner diameter of 40 µm, and an outer diameter of 100 µm. These specific features were optimized via in-vitro experiments in artificial ocular hemispherical structures and subretinal injection of indocyanine green in porcine eye ex-vivo. We confirmed that the ARCMI was capable of delivering ocular drugs by subretinal injection without unusual subretinal tissue damage, including hemorrhage.</abstract><cop>United States</cop><pub>Public Library of Science</pub><pmid>25111562</pmid><doi>10.1371/journal.pone.0104145</doi><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1932-6203 |
ispartof | PloS one, 2014-08, Vol.9 (8), p.e104145 |
issn | 1932-6203 1932-6203 |
language | eng |
recordid | cdi_plos_journals_1552644564 |
source | Publicly Available Content Database (Proquest) (PQ_SDU_P3); PubMed Central |
subjects | Air flow Airflow Animals Biology and Life Sciences Biomimetics Biotechnology Blindness Choroid - cytology Curvature Damage Disorders Drug delivery Drug delivery systems Electroplating Equipment Design Hemorrhage Humans Injection Injectors Macular degeneration Mechanical Phenomena Medicine and Health Sciences Microinjections - adverse effects Microinjections - instrumentation Retina Retina - cytology Swine |
title | An arched micro-injector (ARCMI) for innocuous subretinal injection |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T12%3A25%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_plos_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=An%20arched%20micro-injector%20(ARCMI)%20for%20innocuous%20subretinal%20injection&rft.jtitle=PloS%20one&rft.au=You,%20Yong%20Sung&rft.date=2014-08-11&rft.volume=9&rft.issue=8&rft.spage=e104145&rft.pages=e104145-&rft.issn=1932-6203&rft.eissn=1932-6203&rft_id=info:doi/10.1371/journal.pone.0104145&rft_dat=%3Cproquest_plos_%3E3399487631%3C/proquest_plos_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c526t-7c6c0693453f53bf51ba834638f30f67e9b7a575581ff5095282fef1679aa4f73%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1552644564&rft_id=info:pmid/25111562&rfr_iscdi=true |